MediWound Ltd. , a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally.
Mediwound stock last closed at $14.19, down 0.77% from the previous day, and has decreased 20.99% in one year. It has underperformed other stocks in the Biotechnology industry by 0.09 percentage points. Mediwound stock is currently +4.8% from its 52-week low of $13.54, and -30.1% from its 52-week high of $20.30.
As of Aug 5, 2026, there are 12.87M MDWD shares outstanding. The market cap of MDWD is $182.68M. In the last 24 hours, 65,400 MDWD shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy MDWD stock.
We believe that eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, you need to fill out some personal information so you can invest in MDWD stock today.
Now that you have created your account on one of the best stock market apps, you can securely and quickly fund your account:
Watch the video below if you need help depositing money into your new investment account.
After you have decided on the best place to buy Mediwound stock, it's crucial to analyze their stock before you buy, so you actually comprehend the risk and upside.
WallStreetZen was built to help part-time investors perform better fundamental analysis.
You can see all of the due diligence checks on MDWD's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge MDWD's intrinsic value.
Using relative valuations metrics:
You can access more valuation analysis on MDWD's stock here.
Out of 2 Wall Street analysts who monitor MDWD, the consensus analyst rating on Mediwound is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Mediwound stock forecast page.
Last year, MDWD revenue was $14.48M. Over the past five year, MDWD's revenue has grown by -8.98% per year. This was slower than the Biotechnology industry average of 34.26%.
Find out more about MDWD's earnings and revenue performance here.
In the last year, executives and large shareholders at MDWD have bought more shares than they have sold.
Nachum Shamir, Director of MDWD, was the latest MDWD insider to buy. They bought $2,445.63 worth of MDWD stock on Jun 3, 2026.
Dig into more about who owns MDWD shares here.
No, Mediwound doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
There are two primary types of orders:
Hit the Open Trade button and your broker will place the order.
If you want additional info about buying stocks on eToro, click the helpful video below:
Now that you own some MDWD stock, you'll want to keep up with your new shares.
Put MDWD on a watchlist to monitor your MDWD stock.
To reiterate, here are the 6 steps you need to take to buy Mediwound stock right now:
If you are looking for a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Mediwound, add MDWD to your watchlist by clicking the button below.